methylene blue has been researched along with Malaria, Falciparum in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (32.14) | 29.6817 |
2010's | 18 (64.29) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
Alfano, G; Brindisi, M; Brogi, S; Butini, S; Caldelari, R; Campiani, G; Chemi, G; D'Alessandro, S; Dechering, KJ; Fusi, F; Gemma, S; Gorelli, B; Jez, JM; Koolen, KJM; Lamponi, S; Lee, SG; Parapini, S; Saponara, S; Taramelli, D; Vallone, A | 1 |
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA | 1 |
Compaoré, G; Coulibaly, B; D Alessandro, U; Jahn, A; Kieser, M; Klose, C; Krisam, J; Lu, G; Meissner, P; Mendes Jorge, M; Mockenhaupt, FP; Müller, O; Nebie, E; Ouermi, L; Sié, A | 1 |
Amalvict, R; Benoit, N; Briolant, S; Fonta, I; Gendrot, M; Madamet, M; Mosnier, J; Pradines, B | 1 |
Amalvict, R; Benoit, N; Bercion, R; Briolant, S; Diatta, B; Diawara, S; Fall, B; Fall, M; Gueye, MW; Kounta, MB; Lo, G; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Anvikar, AR; Nath, M; Pillai, CR; Sinha, A; Valecha, N; Wadi, I | 1 |
Price, RN; White, NJ | 1 |
Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
Goldau, N; Jahn, A; Lu, G; Meissner, P; Mendes Jorge, M; Mockenhaupt, FP; Müller, O; Nagbanshi, M | 1 |
Bousema, T; Bradley, J; Churcher, TS; Delves, M; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Mahamar, A; Roh, M; Soumaré, HM | 1 |
Jahn, A; Lu, G; Mockenhaupt, FP; Müller, O | 1 |
Delves, MJ; Herreros, E; Lelièvre, J; López-Barragán, MJ; Marques, S; Ruecker, A; Sinden, RE; Straschil, U | 1 |
Berens-Riha, N; Bountogo, M; Bousema, T; Breitkreutz, J; Coulibaly, B; Drakeley, C; Kieser, M; Klose, C; Meissner, PE; Mockenhaupt, FP; Müller, O; Nebié, E; Pritsch, M; Schirmer, RH; Sié, A; Sirima, SB; Wieser, A | 1 |
Burkard, L; Calderón, AI; Scheuermann, A; Simithy, J | 1 |
Dutta, G; Lapidus, LJ; Lillehoj, PB; Nagarajan, S | 1 |
Coulibaly, B; Klose, C; Mansmann, U; Meissner, PE; Mockenhaupt, FP; Müller, O; Schirmer, RH; Zoungrana, A | 1 |
Bountogo, M; Burhenne, J; Coulibaly, B; Klose, C; Mansmann, U; Meissner, P; Mikus, G; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A | 1 |
Kiara, SM; Mwai, L; Nzila, A; Ochola, LI; Ohuma, E; Okombo, J; Pole, L | 1 |
Buchner, H; Coulibaly, B; Kuhnert, R; Mansmann, U; Marks, B; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I | 1 |
Becher, H; Becker, K; Coulibaly, B; Eubel, J; Kouyaté, B; Merkle, H; Müller, O; Scheiwein, M; Schiek, W; Schirmer, RH; Stich, A; Zich, T | 1 |
Burhenne, J; Fröhlich, M; Haefeli, WE; Hoppe-Tichy, T; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Singh, SK; Tayrouz, Y; Walter-Sack, I | 1 |
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, P; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Sanon, M; Schiek, W; Schirmer, H; Walter-Sack, I; Witte, S; Wüst, K | 1 |
Amaral, L; Wainwright, M | 1 |
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, PE; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Sanon, M; Schiek, W; Schirmer, H; Tapsoba, T; Walter-Sack, I; Witte, S | 1 |
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, PE; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Schiek, W; Schirmer, RH; Tapsoba, T; Walter-Sack, I; Witte, S | 1 |
Bertani, S; Deharo, E; Garavito, G; Landau, I; Maurel, S; Monje, MC; Rincon, J; Valentin, A | 1 |
Coulibaly, B; Klose, C; Kouyaté, B; Mansmann, U; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A | 1 |
4 review(s) available for methylene blue and Malaria, Falciparum
Article | Year |
---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.
Topics: Enzyme Inhibitors; Female; Humans; Malaria, Falciparum; Male; Methylene Blue | 2018 |
Methylene blue as an antimalarial agent.
Topics: Animals; Antimalarials; Clinical Trials as Topic; Glutathione Reductase; Humans; Malaria, Falciparum; Methylene Blue; Oxidation-Reduction; Plasmodium falciparum | 2003 |
The phenothiazinium chromophore and the evolution of antimalarial drugs.
Topics: Animals; Antimalarials; Drug Design; Drug Resistance; Humans; Malaria, Falciparum; Methylene Blue; Oxidation-Reduction; Oxidative Stress; Plasmodium falciparum | 2005 |
11 trial(s) available for methylene blue and Malaria, Falciparum
Article | Year |
---|---|
Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Methylene Blue; Plasmodium falciparum; Primaquine; Treatment Outcome | 2019 |
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Culicidae; Female; Humans; Malaria, Falciparum; Male; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Sex Ratio; Sterilization; Young Adult | 2019 |
Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2015 |
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child; Drug Therapy, Combination; Germ Cells; Humans; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum; Treatment Outcome | 2009 |
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Drug Administration Schedule; Dysuria; Enzyme Inhibitors; Female; Humans; Malaria, Falciparum; Male; Methylene Blue; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Single-Blind Method; Young Adult | 2010 |
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.
Topics: Administration, Oral; Adult; Anti-Infective Agents, Urinary; Antimalarials; Area Under Curve; Chloroquine; Drug Interactions; Female; Half-Life; Humans; Malaria, Falciparum; Male; Methylene Blue | 2004 |
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Glucosephosphate Dehydrogenase Deficiency; Hematocrit; Hemoglobins; Hemolysis; Humans; Malaria, Falciparum; Male; Methylene Blue; Middle Aged; Rural Health | 2005 |
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
Topics: Burkina Faso; Child, Preschool; Chloroquine; Drug Therapy, Combination; Glycogen Storage Disease Type I; Humans; Infant; Malaria, Falciparum; Methylene Blue | 2005 |
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.
Topics: Burkina Faso; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Random Allocation; Treatment Failure | 2006 |
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Amodiaquine; Artemisinins; Artesunate; Burkina Faso; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dysuria; Humans; Malaria, Falciparum; Methylene Blue; Sesquiterpenes; Treatment Outcome; Vomiting | 2008 |
13 other study(ies) available for methylene blue and Malaria, Falciparum
Article | Year |
---|---|
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analog
Topics: Antimalarials; Dose-Response Relationship, Drug; Enzyme Inhibitors; Furans; Life Cycle Stages; Malaria, Falciparum; Methyltransferases; Molecular Structure; Parasitic Sensitivity Tests; Piperidines; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins | 2018 |
Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013-18.
Topics: Africa; Antimalarials; Bayes Theorem; Drug Resistance; France; Humans; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum | 2020 |
Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015.
Topics: Antimalarials; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Parasitic Sensitivity Tests; Plasmodium falciparum; Senegal | 2017 |
Methylene blue induced morphological deformations in Plasmodium falciparum gametocytes: implications for transmission-blocking.
Topics: Antimalarials; Cell Survival; Humans; India; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Microscopy; Parasitic Sensitivity Tests; Plasmodium falciparum | 2018 |
Drugs that reduce transmission of falciparum malaria.
Topics: Humans; Malaria, Falciparum; Mali; Methylene Blue; Plasmodium falciparum; Primaquine; Single-Blind Method | 2018 |
How worthwhile is methylene blue as a treatment of malaria?
Topics: Antimalarials; Humans; Malaria, Falciparum; Methylene Blue; Treatment Outcome | 2019 |
Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.
Topics: Antimalarials; Folic Acid Antagonists; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum; Thiostrepton | 2013 |
Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry.
Topics: Antimalarials; Chromatography, Liquid; Enzyme Assays; Enzyme Inhibitors; Glutathione; Glutathione Reductase; Humans; Malaria, Falciparum; Mass Spectrometry; Methylene Blue; Naphthoquinones; Plasmodium falciparum; Reproducibility of Results; Thiadiazoles | 2016 |
Enzyme-free electrochemical immunosensor based on methylene blue and the electro-oxidation of hydrazine on Pt nanoparticles.
Topics: Antibodies, Protozoan; Biosensing Techniques; Electrochemical Techniques; Humans; Hydrazines; Immunoassay; Malaria, Falciparum; Metal Nanoparticles; Methylene Blue; Models, Molecular; Plasmodium falciparum; Platinum; Proteins; Protozoan Proteins; Reproducibility of Results; Saliva | 2017 |
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.
Topics: Animals; Antimalarials; Humans; Kenya; Malaria, Falciparum; Methylene Blue; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2012 |
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Topics: Anemia; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Randomized Controlled Trials as Topic; Risk | 2013 |
Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum.
Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Parasitic Sensitivity Tests; Plasmodium falciparum; Treatment Outcome | 2007 |